Table 3

Association of male partner circumcision status with sexually transmitted infection outcomes among women

Outcome*All (n=4640)One lifetime partner (n=1317)
Overall weighted prevalence
% (n)
OR (95% CI): all partners circumcised versus any partner uncircumcisedaOR (95% CI): all partners circumcised versus any partner uncircumcised†aOR (95% CI): all partners circumcised versus any partner uncircumcised‡Overall weighted prevalence
% (n)
OR (95% CI): partner circumcised versus uncircumcisedAge-adjusted OR (95% CI): partner circumcised versus uncircumcised†aOR (95% CI): partner circumcised versus uncircumcised§
HSV-276.8 (3618)0.49 (0.42to 0.57)0.68 (0.58to 0.80)0.71 (0.60to 0.84)62.5 (989)0.50 (0.38to 0.65)0.68 (0.52to 0.89)0.71 (0.53to 0.95)
Syphilis1.9 (96)0.83 (0.45 to 1.52)0.70 (0.39 to 1.26)0.74 (0.40 to 1.37)1.2 (21)0.87 (0.20 to 3.84)0.65 (0.16 to 2.65)
Hepatitis B sAg¶3.8 (150)1.17 (0.74 to 1.86)1.18 (0.73 to 1.89)1.26 (0.78 to 2.02)2.3 (29)1.82 (0.54 to 6.15)2.07 (0.59 to 7.27)
HIV49.0 (2392)0.58 (0.48to 0.70)0.67 (0.55to 0.81)0.71 (0.60to 0.84)31.8 (1546)0.60 (0.45to 0.79)0.70 (0.52to 0.93)0.66 (0.49to 0.90)
Neisseria gonorrhoeae3.7 (161)1.31 (0.81 to 2.12)1.02 (0.62 to 1.69)1.04 (0.63 to 1.71)3.1 (49)1.70 (0.70 to 4.15)1.34 (0.49 to 3.69)
Chlamydia trachomatis9.6 (434)1.62 (125to 2.10)1.14 (0.88 to 1.48)1.13 (0.86 to 1.47)11.0 (165)1.71 (1.05to 2.79)1.07 (0.64 to 1.79)1.13 (0.66 to 1.91)
Trichomonas vaginalis14.2 (754)0.95 (0.78 to 1.17)1.01 (0.81 to 1.26)1.09 (0.87 to 1.36)13.4 (216)0.91 (0.63 to 1.31)0.94 (0.64 to 1.40)0.97 (0.64 to 1.48)
Mycoplasma genitalium5.5 (252)1.24 (0.87 to 1.76)0.97 (0.66 to 1.42)1.02 (0.70 to 1.49)5.1 (88)1.20 (0.60 to 2.39)0.86 (0.41 to 1.81)0.93 (0.45 to 1.92)
  • Significant associations (p<0.05) are bolded.

  • *6 women were missing HSV-2 results; 2 women were missing syphilis results; 10 women were missing hepatitis B sAg results; 7 women were missing N. gonorrhoeae, C. trachomatis, T. vaginalis and M. genitalium results.

  • †All models controlled for age only.

  • ‡All models controlled for age (continuous variable, transformed if necessary), education (completed secondary education or not), income (household income ≤R6000, household income >R6000 or household income missing), relationship status (married/in a serious relationship or single), condom use (reports always using a condom with most recent partner during sex or not), drinking before sex (an indicator for whether someone never drank before sex or not) and number of lifetime partners (1–2 partners, 3–4 partners, 5–9 partners, 10+ partners and refused to report).

  • §Except where noted, all models controlled for age (continuous variable, transformed if necessary), an indicator for whether the partner was 5 or more years older, education (completed secondary education or not), income (household income ≤R6000, household income >R6000 or household income missing), relationship status (married/in a serious relationship or single), condom use (reports always using a condom with most recent partner during sex or not) and drinking before sex (an indicator for whether someone never drank before sex or not). #Excludes individuals aged 19 or younger as these individuals should have been vaccinated against HBV in the vaccination programme that started in April 1995.

  • ¶Excludes individuals under age 20 (n=374 women) as these individuals should have been vaccinated against HBV in the vaccination programme that started in April 1995.

  • HBV, hepatitis B virus; HSV-2, herpes simplex virus type 2; aOR, adjusted OR; sAg, surface antigen.